Skip to main content
. 2023 Apr 28;10:1069651. doi: 10.3389/fnut.2023.1069651

FIGURE 3.

FIGURE 3

Baseline immunophenotypic characteristics of patients by ASM and 5TSTS results. (A,B) Percentage of CD45RA+CD45RO– (A) and CD45RA-CD45RO+ (B) cells within the CD4+ T cell population, and (C,D) percentage of CD45RA+CD45RO– (C) and CD45RA-CD45RO+ (D) cells within the CD8+ T cell population of ASM non-responders (NR) and responders (RES). (E) Percentage of CD3+CD56+NK T cells in 5TSTS NR and RES. (F) Naïve/memory cell ratio (CD45RA+CD45RO–/CD45RA-CD45RO+) in the CD8+ cell populations of ASM NR and RES. In panel (F), significant differences between the ratio at baseline and week 12 in ASM RES (two-way ANOVA with post hoc Fisher’s LSD test) are indicated under the bar. Significance of difference between ASM NR and RES (two-way ANOVA with post hoc Fisher’s LSD test) is indicated above the error bar of ASM NR. NR, non-responder; RES, responder; ASM, appendicular skeletal muscle mass; 5TSTS, five times sit-to-stand test; ns, not significant. Unpaired t-test for panels (A–E). *P < 0.05. Data are presented as the mean ± SEM.